These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23344680)

  • 41. A type 2 diabetes screening program by general practioners in a Belgian at risk population.
    Buysschaert M; Vandenbroucke C; Barsoum S
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):109-14. PubMed ID: 11353875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes screening in primary care: the PRE.DI.CO. study.
    Bonaccorsi G; Guarducci S; Ruffoli E; Lorini C
    Ann Ig; 2012; 24(6):527-34. PubMed ID: 23234190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study.
    Garancini MP; Calori G; Ruotolo G; Manara E; Izzo A; Ebbli E; Bozzetti AM; Boari L; Lazzari P; Gallus G
    Diabetologia; 1995 Mar; 38(3):306-13. PubMed ID: 7758877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Screening for type 2 diabetes and prediabetes--methodological concerns and feasibility in Hungary].
    Jermendy G; Hidvégi T; Vándorfi G; Winkler G
    Orv Hetil; 2010 Apr; 151(17):683-90. PubMed ID: 20388611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
    Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
    Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.
    Muñoz-González MC; Lima-Martínez MM; Nava A; Trerotola G; Paoli M; Cabrera-Rego JO; Gonzalez B; Arciniegas A; Paez J
    Med Princ Pract; 2019; 28(4):324-332. PubMed ID: 30852570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.
    Bernabe-Ortiz A; Perel P; Miranda JJ; Smeeth L
    Prim Care Diabetes; 2018 Dec; 12(6):517-525. PubMed ID: 30131300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.
    Colagiuri S; Hussain Z; Zimmet P; Cameron A; Shaw J;
    Diabetes Care; 2004 Feb; 27(2):367-71. PubMed ID: 14747215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying Adult Population at Risk for Undiagnosed Diabetes Mellitus in Medan City, Indonesia Targeted on Diabetes Prevention.
    Siregar FA; Asfriyati ; Makmur T; Bestari R; Lubis IA; Zein U
    Med Arch; 2023; 77(6):455-459. PubMed ID: 38313111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000.
    Icks A; Haastert B; Gandjour A; John J; Löwel H; Holle R; Giani G; Rathmann W;
    Diabetes Care; 2004 Sep; 27(9):2120-8. PubMed ID: 15333472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study.
    Morandi A; Maschio M; Marigliano M; Miraglia Del Giudice E; Moro B; Peverelli P; Maffeis C
    Pediatr Obes; 2014 Feb; 9(1):17-25. PubMed ID: 23296488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [An epidemiological study of abnormal glucose metabolism and its risk factors among middle and aged population with hypertension in Chengdu area].
    Yi YJ; Ran X; Huang XB; Liu Y; Zhang TJ; Ouyang LY; Zeng W; Xu JB; Yang L; Liu Y; Li XJ; Zhao SQ
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):301-4. PubMed ID: 20627035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The prevalence of undiagnosed type 2 diabetes mellitus in consulting rooms of general practitioners].
    Vozár J;
    Vnitr Lek; 2001 Mar; 47(3):140-5. PubMed ID: 15635874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population--the implications of measuring glycated hemoglobin.
    Baral N; Koner BC; Karki P; Ramaprasad C; Lamsal M; Koirala S
    Singapore Med J; 2000 Jun; 41(6):264-7. PubMed ID: 11109341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM; Chia YC; Koay ZL
    Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance.
    Hellgren MI; Daka B; Jansson PA; Lindblad U
    Prim Care Diabetes; 2015 Aug; 9(4):261-6. PubMed ID: 25466159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.